Rights and permissions
About this article
Cite this article
Dalteparin alternative in VTE prevention for patients with cancer. Pharmacoecon. Outcomes News 506, 1 (2006). https://doi.org/10.2165/00151234-200605060-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605060-00001